Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$31.86 - $67.26 $6.69 Million - $14.1 Million
-210,000 Reduced 58.33%
150,000 $6.5 Million
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $16.4 Million - $26.7 Million
360,000 New
360,000 $23.7 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track One Fin Capital Management LP Portfolio

Follow One Fin Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One Fin Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on One Fin Capital Management LP with notifications on news.